Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study. [electronic resource]
- Human gene therapy Feb 1995
- 195-204 p. digital
Publication Type: Journal Article
1043-0342
10.1089/hum.1995.6.2-195 doi
Cell Transplantation Clinical Protocols Clinical Trials, Phase I as Topic Colonic Neoplasms--therapy Fibroblasts Gene Transfer Techniques--adverse effects Genetic Therapy--methods Humans Informed Consent Interleukin-2--genetics